Sec. 105. ENHANCED COMMUNICATION
258 words·~1 min read·
/statute-compilations/comps-10691/sec-105A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 105 ENHANCED COMMUNICATION **[**[21 U.S.C. 353a-1](/us/usc/t21/s353a-1)**]** ###
(a)Submissions From State Boards of Pharmacy In a manner specified by the Secretary of Health and Human Services (referred to in this section as the “Secretary”), the Secretary shall receive submissions from State boards of pharmacy— ####
(1)describing actions taken against compounding pharmacies, as described in subsection (b); or ####
(2)expressing concerns that a compounding pharmacy may be acting contrary to section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a). ###
(b)Content of Submissions From State Boards of Pharmacy An action referred to in subsection (a)(1) is, with respect to a pharmacy that compounds drugs, any of the following: ####
(1)The issuance of a warning letter, or the imposition of sanctions or penalties, by a State for violations of a State’s pharmacy regulations pertaining to compounding. ####
(2)The suspension or revocation of a State-issued pharmacy license or registration for violations of a State’s pharmacy regulations pertaining to compounding. ####
(3)The recall of a compounded drug due to concerns relating to the quality or purity of such drug. ###
(c)Consultation The Secretary shall implement subsection
(a)in consultation with the National Association of Boards of Pharmacy. ###
(d)Notifying State Boards of Pharmacy The Secretary shall immediately notify State boards of pharmacy when— ####
(1)the Secretary receives a submission under subsection (a)(1); or ####
(2)the Secretary makes a determination that a pharmacy is acting contrary to section 503A of the Federal Food, Drug, and Cosmetic Act.
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources